The hypodermic syringes market is expected to continue its stronghold as the market flourishes at an average CAGR of 3.2%. In contrast, the market is valued at US$ 3.51 Bn in 2022 and is projected to reach market revenue of US$ 4.66 Bn through 2032.
The market is anticipated to show promising growth prospects during the forecast period, expanding the hypodermic syringes market size.
| Attributes | Details |
|---|---|
| CAGR (2022 to 2032) | 3.2% |
| Value (2022) | US$ 3.51 Billion |
| Value (2032) | US$ 4.66 Billion |
The term hypodermic explains its application in “hypo,” which stands for beneath. In contrast, “derm” stands for skin, explaining hypodermic syringes to be used in withdrawing the fluid from the body or injecting fluid into the body. As these chronic diseases keep rising, the use of these syringes has been booming. The easing factor also fuels the demand for hypodermic syringes in the medical sector.
A research report on the hypodermic syringes market explains that the leading government initiatives and dosing errors associated with syringes have pushed the sales of hypodermic syringes in healthcare markets. Other factors that drive the traction of the hypodermic syringes market are aggressive price ranges and new schemes. This pushes the sales of hypodermic syringes.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The global hypodermic syringes market is expected to flourish under the backdrop of the global pharmaceutical industry during the forecast period. Hypodermic syringes are preferred over after-filled syringes as they offer fixed dosages of the drug and ease in usability.
Prefill ability helps in reducing the overall cost by reducing the drug overfill. Single-dose vials or multi-dose vials have a drug overfill of almost 20-25% so that the administrator has enough to fill the correct dose and to compensate for human errors, flourishing the demand for hypodermic syringes.
However, prefilled hypodermic syringes eradicate the source of inefficiency in the manufacturing process by eliminating drug overfills. This is particularly advantageous for companies dealing with costly biopharmaceuticals. The growth of the biologics market is likely to boost the hypodermic syringes market.
The conventional syringes were made of glass barrels and glass rods, which were comparatively expensive to manufacture when compared to plastic-based hypodermic syringes, pushing the sales of hypodermic syringes globally.
Healthcare workers benefit from accurate and pre-measured doses. Demand for hypodermic syringes is also fueled by reduced dosing, medication errors, and decreased microbial contamination risk. Along with this, an increasing trend of people getting vaccinated outside hospitals such as in schools, community centers, pharmacies, and airport booths is likely to contribute to the growth of the hypodermic syringes market.
Geographically, the global hypodermic syringes market has been divided into seven key regions: North America, Latin America, East Asia, South Asia, Europe, the Middle East & Africa (MEA), and Oceania. Europe is expected to hold maximum market share in the global hypodermic syringes market owing to the well-established healthcare industry in the region.
The healthcare sector in India is diversified and offers enormous opportunities in every segment, which includes payers, providers, and medical technology. Increasing competition pushing businesses to explore and adapt according to the latest trends and dynamics is expected to impact the hypodermic syringes market in the country positively.
Principal Consultant
The key players in the hypodermic syringes market are focusing on mergers and collaborations that are fueling the sales of Hypodermic syringes including Terumo Corporation, Albert David Ltd., Becton, Dickinson and Company, Nipro Corporation, Smiths Medical, Hindustan Syringes & Medical Devices Limited etc.
Recent Market Development:
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 3.2% from 2022 to 2032 |
| Base year for estimation | 2021 |
| Historical data | 2015 to 2021 |
| Forecast period | 2022 to 2032 |
| Quantitative units | Revenue in USD Million, and CAGR from 2022 to 2032 |
| Report coverage | Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends, Pricing Analysis, |
| Segments covered | Material type, Sales Channel, End-user, Region |
| Regional scope | North America; Western Europe; Eastern Europe; Middle East; Africa; ASEAN; South Asia; Rest of Asia; Australia and New Zealand |
| Country scope | USA, Canada, Mexico, Germany, UK, France, Italy, Spain, Russia, Belgium, Poland, Czech Republic, China, India, Japan, Australia, Brazil, Argentina, Colombia, Saudi Arabia, UAE, Iran, South Africa |
| Key companies profiled | Terumo Corporation; Albert David Ltd.; Becton; Dickinson and Company; Nipro Corporation; Smiths Medical; Hindustan Syringes & Medical Devices Limited etc. |
| Customization scope | Free report customization (equivalent to up to 8 analysts' working days) with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The hypodermic syringes market is set to thrive at a CAGR of 3.2% through 2032.
Europe holds the biggest revenue in the hypodermic syringes market, the region’s growth owing to its application in healthcare as it eases out the diagnostic and clinical procedures coupled with the spread of covid-19. This leads to the high demand for hypodermic syringes in developed countries like Spain and France.
Demand for hypodermic syringes market size has expanded owing to their use as sustainable tool for withdrawing the fluids as well as injecting the fluid beneath the human skin.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Hypodermic Syringes Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) & Volume (Units) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Hypodermic Syringes Market Analysis 2017-2021 and Forecast 2022-2032, By Material Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Material Type, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Material Type, 2022-2032
5.3.1. Polymer Syringes
5.3.2. Cyclic Olefin Polymers (COP)
5.3.3. Cyclic Olefin Copolymers (COC)
5.3.4. Polypropylene and Other Polymers
5.3.5. Glass Syringes
5.4. Y-o-Y Growth Trend Analysis By Material Type, 2017-2021
5.5. Absolute $ Opportunity Analysis By Material Type, 2022-2032
6. Global Hypodermic Syringes Market Analysis 2017-2021 and Forecast 2022-2032, By Sales Channel
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Sales Channel, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Sales Channel, 2022-2032
6.3.1. Manufacturers
6.3.2. Distributors
6.3.3. Retailers
6.4. Y-o-Y Growth Trend Analysis By Sales Channel, 2017-2021
6.5. Absolute $ Opportunity Analysis By Sales Channel, 2022-2032
7. Global Hypodermic Syringes Market Analysis 2017-2021 and Forecast 2022-2032, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By End User, 2017-2021
7.3. Current and Future Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By End User, 2022-2032
7.3.1. Hospital
7.3.2. Diabetic Care Centers
7.3.3. Blood Collection Centers
7.3.4. Veterinary Care Centers
7.3.5. Clinics
7.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021
7.5. Absolute $ Opportunity Analysis By End User, 2022-2032
8. Global Hypodermic Syringes Market Analysis 2017-2021 and Forecast 2022-2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Mn) & Volume (Units) Analysis By Region, 2017-2021
8.3. Current Market Size Value (US$ Mn) & Volume (Units) Analysis and Forecast By Region, 2022-2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Hypodermic Syringes Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. By Material Type
9.2.3. By Sales Channel
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Material Type
9.3.3. By Sales Channel
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Hypodermic Syringes Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Argentina
10.2.1.4. Chile
10.2.1.5. Peru
10.2.1.6. Rest of Latin America
10.2.2. By Material Type
10.2.3. By Sales Channel
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Material Type
10.3.3. By Sales Channel
10.3.4. By End User
10.4. Key Takeaways
11. Europe Hypodermic Syringes Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. Italy
11.2.1.3. France
11.2.1.4. U.K.
11.2.1.5. Spain
11.2.1.6. Russia
11.2.1.7. BENELUX
11.2.1.8. Rest of Europe
11.2.2. By Material Type
11.2.3. By Sales Channel
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Material Type
11.3.3. By Sales Channel
11.3.4. By End User
11.4. Key Takeaways
12. Asia Pacific Hypodermic Syringes Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.1.4. Rest of Asia Pacific
12.2.2. By Material Type
12.2.3. By Sales Channel
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Material Type
12.3.3. By Sales Channel
12.3.4. By End User
12.4. Key Takeaways
13. Middle East and Africa Hypodermic Syringes Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) & Volume (Units) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) & Volume (Units) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. South Africa
13.2.1.3. Turkey
13.2.1.4. Rest of Middle East and Africa
13.2.2. By Material Type
13.2.3. By Sales Channel
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Material Type
13.3.3. By Sales Channel
13.3.4. By End User
13.4. Key Takeaways
14. Key Countries Hypodermic Syringes Market Analysis
14.1. U.S.
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2021
14.1.2.1. By Material Type
14.1.2.2. By Sales Channel
14.1.2.3. By End User
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2021
14.2.2.1. By Material Type
14.2.2.2. By Sales Channel
14.2.2.3. By End User
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2021
14.3.2.1. By Material Type
14.3.2.2. By Sales Channel
14.3.2.3. By End User
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2021
14.4.2.1. By Material Type
14.4.2.2. By Sales Channel
14.4.2.3. By End User
14.5. Argentina
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2021
14.5.2.1. By Material Type
14.5.2.2. By Sales Channel
14.5.2.3. By End User
14.6. Chile
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2021
14.6.2.1. By Material Type
14.6.2.2. By Sales Channel
14.6.2.3. By End User
14.7. Peru
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2021
14.7.2.1. By Material Type
14.7.2.2. By Sales Channel
14.7.2.3. By End User
14.8. Germany
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2021
14.8.2.1. By Material Type
14.8.2.2. By Sales Channel
14.8.2.3. By End User
14.9. Italy
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2021
14.9.2.1. By Material Type
14.9.2.2. By Sales Channel
14.9.2.3. By End User
14.10. France
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2021
14.10.2.1. By Material Type
14.10.2.2. By Sales Channel
14.10.2.3. By End User
14.11. U.K.
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2021
14.11.2.1. By Material Type
14.11.2.2. By Sales Channel
14.11.2.3. By End User
14.12. Spain
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2021
14.12.2.1. By Material Type
14.12.2.2. By Sales Channel
14.12.2.3. By End User
14.13. Russia
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2021
14.13.2.1. By Material Type
14.13.2.2. By Sales Channel
14.13.2.3. By End User
14.14. BENELUX
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2021
14.14.2.1. By Material Type
14.14.2.2. By Sales Channel
14.14.2.3. By End User
14.15. China
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2021
14.15.2.1. By Material Type
14.15.2.2. By Sales Channel
14.15.2.3. By End User
14.16. Japan
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2021
14.16.2.1. By Material Type
14.16.2.2. By Sales Channel
14.16.2.3. By End User
14.17. South Korea
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2021
14.17.2.1. By Material Type
14.17.2.2. By Sales Channel
14.17.2.3. By End User
14.18. GCC Countries
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2021
14.18.2.1. By Material Type
14.18.2.2. By Sales Channel
14.18.2.3. By End User
14.19. South Africa
14.19.1. Pricing Analysis
14.19.2. Market Share Analysis, 2021
14.19.2.1. By Material Type
14.19.2.2. By Sales Channel
14.19.2.3. By End User
14.20. Turkey
14.20.1. Pricing Analysis
14.20.2. Market Share Analysis, 2021
14.20.2.1. By Material Type
14.20.2.2. By Sales Channel
14.20.2.3. By End User
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Material Type
15.3.3. By Sales Channel
15.3.4. By End User
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Terumo Corporation
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.1.5.2. Product Strategy
16.1.1.5.3. Channel Strategy
16.1.2. Albert David
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.2.5.2. Product Strategy
16.1.2.5.3. Channel Strategy
16.1.3. Becton, Dickinson and Company
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.3.5.2. Product Strategy
16.1.3.5.3. Channel Strategy
16.1.4. Nipro Corporation
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.4.5.2. Product Strategy
16.1.4.5.3. Channel Strategy
16.1.5. Smiths Medical
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.5.5.2. Product Strategy
16.1.5.5.3. Channel Strategy
16.1.6. Hindustan Syringes & Medical Devices Limited
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.6.5.2. Product Strategy
16.1.6.5.3. Channel Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
Explore Packaging Insights
View Reports
Hypodermic Syringes Market
